Validation of ClarityDX Prostate as a Reflex Test to Refine the Prediction of Clinically-significant Prostate Cancer
Condition: Prostate Cancer Intervention: Diagnostic Test: Blood test: ClarityDX Prostate Sponsors: Nanostics; Alberta Prostate Cancer Research Initiative, APCaRI; DynaLIFE Medical Laboratories; Prostate Cencer Centre, Calgary; Northern Alberta Urology Centre; Alberta Cancer Foundation; Alberta Innovates Health Solutions; Motorcycle Ride for Dad; Univers ity Hospital Foundation - The Kaye Fund Competition Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Hospitals | Nanotechnology | Prostate Cancer | Reflex Sympathetic Dystrophy | Research | Urology & Nephrology